Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Orexigen
Orexigen
Opportunity In The Weight Loss Drug Market
Seeking Alpha
Tue, 02/21/12 - 07:19 pm
obesity
Vivus
Qnexa
Abbott Laboratories
Alkermes
GSK
JNJ
Roche
Orexigen
No Way? Obesity Drugs Have Side Effects
Motley Fool
Sat, 02/18/12 - 12:11 pm
Vivus
obesity
Qnexa
Orexigen
Contrave
Arena Pharmaceuticals
3 Biotech Companies Down But Not Out
Seeking Alpha
Wed, 02/8/12 - 09:34 am
Arena
Vivus
Orexigen
Biocryst
BioSante
Orexigen surges on FDA trial pact for troubled weight loss drug
Fierce Biotech
Tue, 02/7/12 - 10:50 am
FDA
Orexigen
Contrave
obesity
Diet Pill Scorecard: Vivus, Arena, Orexigen Still Chasing Market Approvals
Minyanville
Fri, 01/13/12 - 10:26 am
Vivus
Arena
Orexigen
obesity
lorcaserin
Qnexa
Contrave
A Diet Pill Comeback? Orexigen Revives Its Drug
Pharmalot
Wed, 09/21/11 - 09:26 am
obesity
Orexigen
Contrave
FDA
Arena Pharmaceuticals Shares Popped: What You Need to Know
Motley Fool
Sat, 09/17/11 - 02:52 pm
Arena Pharmaceuticals
Orexigen
Vivus
Qnexa
weight loss
obesity
A Shrinking Obesity Market
Motley Fool
Sat, 09/17/11 - 02:51 pm
weight loss
Vivus
Qnexa
Orexigen
Arena Pharmaceuticals
When to Buy Biotechnology Stocks?
Seeking Alpha
Mon, 08/15/11 - 10:30 am
Alexion
Arena Pharmaceuticals
Dendreon
Human Genome Sciences
MannKind
Orexigen
Orexigen Revisited: Chances for Contrave Approval Seem Slim
Seeking Alpha
Wed, 08/10/11 - 05:29 pm
Contrave
Orexigen
obesity
The 15 Most-Watched Biotech Stocks
Motley Fool
Mon, 07/11/11 - 06:52 pm
biotech
Gilead Sciences
Dendreon
PDL Biopharma
Cell Therapeutics
Amgen
Aeterna Zentaris
Xoma
Geron
Orexigen
Zalicus
Spectrum Pharmaceuticals
Ariad Pharmaceuticals
Biogen Idec
Momenta
StemCells
8 Potential Biotech Acquisition Candidates
Seeking Alpha
Mon, 06/20/11 - 09:30 am
biotech
M&A
Arena Pharmaceuticals
Biomarin
Dendreon
Human Genome Sciences
Keryx
MannKind
Novartis
Orexigen
Vivus
3 Ways to Play Biotech With Options
Motley Fool
Tue, 06/14/11 - 08:05 pm
Amarin
SIGA technologies
Acorda Therapeutics
Orexigen
Vivus
FDA Bullies Obesity Drugmakers
Motley Fool
Sat, 06/4/11 - 10:06 am
Orexigen
Contrave
Vivus
Qnexa
Arena Pharmaceuticals
obesity
weight loss
Orexigen puts obesity drug development on hold
Yahoo/AP
Sat, 06/4/11 - 09:51 am
Orexigen
obesity
weight loss
Contrave
Orexigen puts US obesity drug development on hold, cites FDA demands, shares skid in premarket
Yahoo/AP
Fri, 06/3/11 - 09:19 am
FDA
Orexigen
obesity
Contrave
Orexigen shares jump on new hope for Contrave
Yahoo/AP
Wed, 06/1/11 - 06:39 pm
Contrave
Orexigen
obesity
Arena's New Data Doesn't Change Obesity Pill Outlook
Investopedia
Mon, 05/30/11 - 06:39 pm
obesity
Arena Pharmaceuticals
Human Genome Sciences
Dendreon
Orexigen
Vivus
Vanda
Arena, Orexigen and Vivus: An Update on Their Obesity Drugs
Seeking Alpha
Sat, 05/28/11 - 12:00 pm
Arena Pharmaceuticals
Orexigen
Vivus
obesity
Qnexa
weight loss
Contrave
Orexigen Therapeutics posts smaller 1Q loss
Yahoo/AP
Mon, 05/9/11 - 04:59 pm
Orexigen
earnings
Contrave
Pages
« first
‹ previous
…
7
8
9
10
11
12
13
14
15
…
next ›
last »